Industry Research Reports
Home > Reports > Chemical & Material > Global Oligonucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Oligonucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-26
Pages: 151 Pages
Report ld: 5282733
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Oligonucleotide Market Size(US$)
CAGR 2025-2031
10.1%
Market Size,2031
USD 2,967
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,666 million
Market Forecast in 2031(Value)
US$ 2,967 million
CAGR
10.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Oligonucleotide market is projected to grow from US$ 1527 million in 2024 to US$ 2967 million by 2031, at a CAGR of 10.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Oligonucleotide market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Abbott Molecular
- PerkinElmer
- SciGene Corporation
- Roche NimbleGen
- CytoTest
- Oligo Factory
- Danaher
- Thermo Fisher Scientific
- GE
- Merck
- Eurofins Scientific
- Agilent
- SUMITOMO CHEMICAL
- Bachem
- Sylentis
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- DNA
- RNA
Segment by Application
- Gene Chip
- Electrophoresis
- Fluorescence In Situ Hybridization
CHAPTER OUTLINE
Chapter 1: Defines the Oligonucleotide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Oligonucleotide: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Oligonucleotide Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 DNA
1.2.3 RNA
1.3 Market Segmentation by Application
1.3.1 Global Oligonucleotide Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Gene Chip
1.3.3 Electrophoresis
1.3.4 Fluorescence In Situ Hybridization
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oligonucleotide Revenue Estimates and Forecasts 2020-2031
2.2 Global Oligonucleotide Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Oligonucleotide Sales Estimates and Forecasts 2020-2031
2.4 Global Oligonucleotide Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Oligonucleotide Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Oligonucleotide Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Oligonucleotide Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 DNA Market Size by Manufacturers
4.5.2 RNA Market Size by Manufacturers
4.6 Global Oligonucleotide Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Oligonucleotide Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Oligonucleotide Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Oligonucleotide Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Oligonucleotide Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Oligonucleotide Sales and Revenue by Type (2020-2031)
7.4 North America Oligonucleotide Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Oligonucleotide Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Oligonucleotide Sales and Revenue by Type (2020-2031)
8.4 Europe Oligonucleotide Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Oligonucleotide Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Oligonucleotide Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Oligonucleotide Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Oligonucleotide Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Oligonucleotide Sales and Revenue by Type (2020-2031)
10.4 Central and South America Oligonucleotide Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Oligonucleotide Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Oligonucleotide Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Oligonucleotide Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Oligonucleotide Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Abbott Molecular
12.1.1 Abbott Molecular Corporation Information
12.1.2 Abbott Molecular Business Overview
12.1.3 Abbott Molecular Oligonucleotide Product Models, Descriptions and Specifications
12.1.4 Abbott Molecular Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Abbott Molecular Oligonucleotide Sales by Product in 2024
12.1.6 Abbott Molecular Oligonucleotide Sales by Application in 2024
12.1.7 Abbott Molecular Oligonucleotide Sales by Geographic Area in 2024
12.1.8 Abbott Molecular Oligonucleotide SWOT Analysis
12.1.9 Abbott Molecular Recent Developments
12.2 PerkinElmer
12.2.1 PerkinElmer Corporation Information
12.2.2 PerkinElmer Business Overview
12.2.3 PerkinElmer Oligonucleotide Product Models, Descriptions and Specifications
12.2.4 PerkinElmer Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 PerkinElmer Oligonucleotide Sales by Product in 2024
12.2.6 PerkinElmer Oligonucleotide Sales by Application in 2024
12.2.7 PerkinElmer Oligonucleotide Sales by Geographic Area in 2024
12.2.8 PerkinElmer Oligonucleotide SWOT Analysis
12.2.9 PerkinElmer Recent Developments
12.3 SciGene Corporation
12.3.1 SciGene Corporation Corporation Information
12.3.2 SciGene Corporation Business Overview
12.3.3 SciGene Corporation Oligonucleotide Product Models, Descriptions and Specifications
12.3.4 SciGene Corporation Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 SciGene Corporation Oligonucleotide Sales by Product in 2024
12.3.6 SciGene Corporation Oligonucleotide Sales by Application in 2024
12.3.7 SciGene Corporation Oligonucleotide Sales by Geographic Area in 2024
12.3.8 SciGene Corporation Oligonucleotide SWOT Analysis
12.3.9 SciGene Corporation Recent Developments
12.4 Roche NimbleGen
12.4.1 Roche NimbleGen Corporation Information
12.4.2 Roche NimbleGen Business Overview
12.4.3 Roche NimbleGen Oligonucleotide Product Models, Descriptions and Specifications
12.4.4 Roche NimbleGen Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Roche NimbleGen Oligonucleotide Sales by Product in 2024
12.4.6 Roche NimbleGen Oligonucleotide Sales by Application in 2024
12.4.7 Roche NimbleGen Oligonucleotide Sales by Geographic Area in 2024
12.4.8 Roche NimbleGen Oligonucleotide SWOT Analysis
12.4.9 Roche NimbleGen Recent Developments
12.5 CytoTest
12.5.1 CytoTest Corporation Information
12.5.2 CytoTest Business Overview
12.5.3 CytoTest Oligonucleotide Product Models, Descriptions and Specifications
12.5.4 CytoTest Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 CytoTest Oligonucleotide Sales by Product in 2024
12.5.6 CytoTest Oligonucleotide Sales by Application in 2024
12.5.7 CytoTest Oligonucleotide Sales by Geographic Area in 2024
12.5.8 CytoTest Oligonucleotide SWOT Analysis
12.5.9 CytoTest Recent Developments
12.6 Oligo Factory
12.6.1 Oligo Factory Corporation Information
12.6.2 Oligo Factory Business Overview
12.6.3 Oligo Factory Oligonucleotide Product Models, Descriptions and Specifications
12.6.4 Oligo Factory Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Oligo Factory Recent Developments
12.7 Danaher
12.7.1 Danaher Corporation Information
12.7.2 Danaher Business Overview
12.7.3 Danaher Oligonucleotide Product Models, Descriptions and Specifications
12.7.4 Danaher Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Danaher Recent Developments
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Corporation Information
12.8.2 Thermo Fisher Scientific Business Overview
12.8.3 Thermo Fisher Scientific Oligonucleotide Product Models, Descriptions and Specifications
12.8.4 Thermo Fisher Scientific Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Thermo Fisher Scientific Recent Developments
12.9 GE
12.9.1 GE Corporation Information
12.9.2 GE Business Overview
12.9.3 GE Oligonucleotide Product Models, Descriptions and Specifications
12.9.4 GE Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 GE Recent Developments
12.10 Merck
12.10.1 Merck Corporation Information
12.10.2 Merck Business Overview
12.10.3 Merck Oligonucleotide Product Models, Descriptions and Specifications
12.10.4 Merck Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Merck Recent Developments
12.11 Eurofins Scientific
12.11.1 Eurofins Scientific Corporation Information
12.11.2 Eurofins Scientific Business Overview
12.11.3 Eurofins Scientific Oligonucleotide Product Models, Descriptions and Specifications
12.11.4 Eurofins Scientific Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Eurofins Scientific Recent Developments
12.12 Agilent
12.12.1 Agilent Corporation Information
12.12.2 Agilent Business Overview
12.12.3 Agilent Oligonucleotide Product Models, Descriptions and Specifications
12.12.4 Agilent Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Agilent Recent Developments
12.13 SUMITOMO CHEMICAL
12.13.1 SUMITOMO CHEMICAL Corporation Information
12.13.2 SUMITOMO CHEMICAL Business Overview
12.13.3 SUMITOMO CHEMICAL Oligonucleotide Product Models, Descriptions and Specifications
12.13.4 SUMITOMO CHEMICAL Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 SUMITOMO CHEMICAL Recent Developments
12.14 Bachem
12.14.1 Bachem Corporation Information
12.14.2 Bachem Business Overview
12.14.3 Bachem Oligonucleotide Product Models, Descriptions and Specifications
12.14.4 Bachem Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Bachem Recent Developments
12.15 Sylentis
12.15.1 Sylentis Corporation Information
12.15.2 Sylentis Business Overview
12.15.3 Sylentis Oligonucleotide Product Models, Descriptions and Specifications
12.15.4 Sylentis Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Sylentis Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Oligonucleotide Industry Chain
13.2 Oligonucleotide Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Oligonucleotide Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Oligonucleotide Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Oligonucleotide Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Oligonucleotide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Oligonucleotide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Oligonucleotide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Oligonucleotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Oligonucleotide Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Oligonucleotide Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Oligonucleotide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Oligonucleotide Sales by Region (2020-2025) & (MT)
Table 8. Global Oligonucleotide Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Oligonucleotide Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 11. Global Oligonucleotide Production by Region (2020-2025) & (MT)
Table 12. Global Oligonucleotide Production by Region (2026-2031) & (MT)
Table 13. Global Oligonucleotide Sales by Manufacturers (2020-2025) & (MT)
Table 14. Global Oligonucleotide Sales Share by Manufacturers (2020-2025)
Table 15. Global Oligonucleotide Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Oligonucleotide Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Oligonucleotide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide as of 2024)
Table 19. Global Oligonucleotide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Oligonucleotide Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Oligonucleotide Manufacturing Base and Headquarters
Table 22. Global Oligonucleotide Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 26. Global Oligonucleotide Sales by Type (2026-2031) & (MT)
Table 27. Global Oligonucleotide Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Oligonucleotide Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Oligonucleotide ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 32. Global Oligonucleotide Sales by Application (2026-2031) & (MT)
Table 33. Oligonucleotide High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Oligonucleotide Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Oligonucleotide Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Oligonucleotide ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Oligonucleotide Growth Accelerators and Market Barriers
Table 40. North America Oligonucleotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Oligonucleotide Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Oligonucleotide Growth Accelerators and Market Barriers
Table 43. Europe Oligonucleotide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Oligonucleotide Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Oligonucleotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Oligonucleotide Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Oligonucleotide Growth Accelerators and Market Barriers
Table 48. Southeast Asia Oligonucleotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Oligonucleotide Investment Opportunities and Key Challenges
Table 50. Central and South America Oligonucleotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Oligonucleotide Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Oligonucleotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Abbott Molecular Corporation Information
Table 54. Abbott Molecular Description and Major Businesses
Table 55. Abbott Molecular Product Models, Descriptions and Specifications
Table 56. Abbott Molecular Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Abbott Molecular Sales Value Proportion by Product in 2024
Table 58. Abbott Molecular Sales Value Proportion by Application in 2024
Table 59. Abbott Molecular Sales Value Proportion by Geographic Area in 2024
Table 60. Abbott Molecular Oligonucleotide SWOT Analysis
Table 61. Abbott Molecular Recent Developments
Table 62. PerkinElmer Corporation Information
Table 63. PerkinElmer Description and Major Businesses
Table 64. PerkinElmer Product Models, Descriptions and Specifications
Table 65. PerkinElmer Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. PerkinElmer Sales Value Proportion by Product in 2024
Table 67. PerkinElmer Sales Value Proportion by Application in 2024
Table 68. PerkinElmer Sales Value Proportion by Geographic Area in 2024
Table 69. PerkinElmer Oligonucleotide SWOT Analysis
Table 70. PerkinElmer Recent Developments
Table 71. SciGene Corporation Corporation Information
Table 72. SciGene Corporation Description and Major Businesses
Table 73. SciGene Corporation Product Models, Descriptions and Specifications
Table 74. SciGene Corporation Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. SciGene Corporation Sales Value Proportion by Product in 2024
Table 76. SciGene Corporation Sales Value Proportion by Application in 2024
Table 77. SciGene Corporation Sales Value Proportion by Geographic Area in 2024
Table 78. SciGene Corporation Oligonucleotide SWOT Analysis
Table 79. SciGene Corporation Recent Developments
Table 80. Roche NimbleGen Corporation Information
Table 81. Roche NimbleGen Description and Major Businesses
Table 82. Roche NimbleGen Product Models, Descriptions and Specifications
Table 83. Roche NimbleGen Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. Roche NimbleGen Sales Value Proportion by Product in 2024
Table 85. Roche NimbleGen Sales Value Proportion by Application in 2024
Table 86. Roche NimbleGen Sales Value Proportion by Geographic Area in 2024
Table 87. Roche NimbleGen Oligonucleotide SWOT Analysis
Table 88. Roche NimbleGen Recent Developments
Table 89. CytoTest Corporation Information
Table 90. CytoTest Description and Major Businesses
Table 91. CytoTest Product Models, Descriptions and Specifications
Table 92. CytoTest Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. CytoTest Sales Value Proportion by Product in 2024
Table 94. CytoTest Sales Value Proportion by Application in 2024
Table 95. CytoTest Sales Value Proportion by Geographic Area in 2024
Table 96. CytoTest Oligonucleotide SWOT Analysis
Table 97. CytoTest Recent Developments
Table 98. Oligo Factory Corporation Information
Table 99. Oligo Factory Description and Major Businesses
Table 100. Oligo Factory Product Models, Descriptions and Specifications
Table 101. Oligo Factory Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Oligo Factory Recent Developments
Table 103. Danaher Corporation Information
Table 104. Danaher Description and Major Businesses
Table 105. Danaher Product Models, Descriptions and Specifications
Table 106. Danaher Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Danaher Recent Developments
Table 108. Thermo Fisher Scientific Corporation Information
Table 109. Thermo Fisher Scientific Description and Major Businesses
Table 110. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 111. Thermo Fisher Scientific Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Thermo Fisher Scientific Recent Developments
Table 113. GE Corporation Information
Table 114. GE Description and Major Businesses
Table 115. GE Product Models, Descriptions and Specifications
Table 116. GE Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. GE Recent Developments
Table 118. Merck Corporation Information
Table 119. Merck Description and Major Businesses
Table 120. Merck Product Models, Descriptions and Specifications
Table 121. Merck Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Merck Recent Developments
Table 123. Eurofins Scientific Corporation Information
Table 124. Eurofins Scientific Description and Major Businesses
Table 125. Eurofins Scientific Product Models, Descriptions and Specifications
Table 126. Eurofins Scientific Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Eurofins Scientific Recent Developments
Table 128. Agilent Corporation Information
Table 129. Agilent Description and Major Businesses
Table 130. Agilent Product Models, Descriptions and Specifications
Table 131. Agilent Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Agilent Recent Developments
Table 133. SUMITOMO CHEMICAL Corporation Information
Table 134. SUMITOMO CHEMICAL Description and Major Businesses
Table 135. SUMITOMO CHEMICAL Product Models, Descriptions and Specifications
Table 136. SUMITOMO CHEMICAL Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. SUMITOMO CHEMICAL Recent Developments
Table 138. Bachem Corporation Information
Table 139. Bachem Description and Major Businesses
Table 140. Bachem Product Models, Descriptions and Specifications
Table 141. Bachem Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Bachem Recent Developments
Table 143. Sylentis Corporation Information
Table 144. Sylentis Description and Major Businesses
Table 145. Sylentis Product Models, Descriptions and Specifications
Table 146. Sylentis Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Sylentis Recent Developments
Table 148. Key Raw Materials Distribution
Table 149. Raw Materials Key Suppliers
Table 150. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 151. Milestones in Production Technology Evolution
Table 152. Distributors List
Table 153. Market Trends and Market Evolution
Table 154. Market Drivers and Opportunities
Table 155. Market Challenges, Risks, and Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Oligonucleotide Product Picture
Figure 2. Global Oligonucleotide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. DNA Product Picture
Figure 4. RNA Product Picture
Figure 5. Global Oligonucleotide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Gene Chip
Figure 7. Electrophoresis
Figure 8. Fluorescence In Situ Hybridization
Figure 9. Oligonucleotide Report Years Considered
Figure 10. Global Oligonucleotide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 12. Global Oligonucleotide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Oligonucleotide Revenue Market Share by Region (2020-2031)
Figure 14. Global Oligonucleotide Sales (2020-2031) & (MT)
Figure 15. Global Oligonucleotide Sales (CAGR) by Region (2020-2031) (MT)
Figure 16. Global Oligonucleotide Sales Market Share by Region (2020-2031)
Figure 17. Global Oligonucleotide Capacity, Production and Utilization (2020-2031) & (MT)
Figure 18. Global Oligonucleotide Production Trend by Region (2020-2031) (MT)
Figure 19. Global Oligonucleotide Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Oligonucleotide Production Growth Rate in North America (2020-2031) & (MT)
Figure 22. Oligonucleotide Production Growth Rate in Europe (2020-2031) & (MT)
Figure 23. Oligonucleotide Production Growth Rate in China (2020-2031) & (MT)
Figure 24. Oligonucleotide Production Growth Rate in Japan (2020-2031) & (MT)
Figure 25. Top 5 and Top 10 Manufacturers Oligonucleotide Sales Volume Market Share in 2024
Figure 26. Global Oligonucleotide Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. DNA Revenue Market Share by Manufacturer in 2024
Figure 29. RNA Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Oligonucleotide Sales Market Share by Type (2020-2031)
Figure 33. Global Oligonucleotide Revenue Market Share by Type (2020-2031)
Figure 34. Global Oligonucleotide Sales Market Share by Application (2020-2031)
Figure 35. Global Oligonucleotide Revenue Market Share by Application (2020-2031)
Figure 36. North America Oligonucleotide Sales YoY (2020-2031) & (MT)
Figure 37. North America Oligonucleotide Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Oligonucleotide Sales Revenue (US$ Million) in 2024
Figure 39. North America Oligonucleotide Sales Volume (MT) by Type (2020- 2031)
Figure 40. North America Oligonucleotide Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Oligonucleotide Sales Volume (MT) by Application (2020-2031)
Figure 42. North America Oligonucleotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Oligonucleotide Sales YoY (2020-2031) & (MT)
Figure 47. Europe Oligonucleotide Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Oligonucleotide Sales Revenue (US$ Million) in 2024
Figure 49. Europe Oligonucleotide Sales Volume (MT) by Type (2020-2031)
Figure 50. Europe Oligonucleotide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Oligonucleotide Sales Volume (MT) by Application (2020-2031)
Figure 52. Europe Oligonucleotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 54. France Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Oligonucleotide Sales YoY (2020-2031) & (MT)
Figure 59. Asia-Pacific Oligonucleotide Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Oligonucleotide Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Oligonucleotide Sales Volume (MT) by Type (2020- 2031)
Figure 62. Asia-Pacific Oligonucleotide Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Oligonucleotide Sales Volume (MT) by Application (2020-2031)
Figure 64. Asia-Pacific Oligonucleotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 69. India Oligonucleotide Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Oligonucleotide Sales YoY (2020-2031) & (MT)
Figure 71. Central and South America Oligonucleotide Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Oligonucleotide Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Oligonucleotide Sales Volume (MT) by Type (2021-2031)
Figure 74. Central and South America Oligonucleotide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Oligonucleotide Sales Volume (MT) by Application (2020-2031)
Figure 76. Central and South America Oligonucleotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Oligonucleotide Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Oligonucleotide Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Oligonucleotide Sales YoY (2020-2031) & (MT)
Figure 80. Middle East and Africa Oligonucleotide Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Oligonucleotide Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Oligonucleotide Sales Volume (MT) by Type (2021-2031)
Figure 83. South America Oligonucleotide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Oligonucleotide Sales Volume (MT) by Application (2020-2031)
Figure 85. Middle East and Africa Oligonucleotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Oligonucleotide Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Oligonucleotide Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Oligonucleotide Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Oligonucleotide Revenue (2020-2025) & (US$ Million)
Figure 90. Oligonucleotide Industry Chain Mapping
Figure 91. Regional Oligonucleotide Manufacturing Base Distribution (%)
Figure 92. Oligonucleotide Production Process
Figure 93. Regional Oligonucleotide Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 10.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Oligonucleotide market size from 2025 to 2031?
Which companies rank high in the global Oligonucleotide market?
What was the global market size of Oligonucleotide in 2025?
What was the global market size of Oligonucleotide in 2031?
Related Reports
Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oligonucleotide was estimated to be worth US$ 1666 million in 2025 and is projected to reach US$ 3237 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 144
USD 3950.00
(Single User License)
Global Oligonucleotide Market Research Report 2026
The global Oligonucleotide market was valued at US$ 1666 million in 2025 and is anticipated to reach US$ 3237 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 137
USD 2900.00
(Single User License)
Global Oligonucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oligonucleotide market size was US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 92
USD 4250.00
(Single User License)
Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oligonucleotide was estimated to be worth US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 114
USD 3950.00
(Single User License)
Global Oligonucleotide Market Research Report 2025
The global market for Oligonucleotide was valued at US$ 1527 million in the year 2024 and is projected to reach a revised size of US$ 2967 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published Date: 2025-02-24
Pages: 101
USD 2900.00
(Single User License)
Oligonucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published Date: 2024-01-16
Pages: 144
USD 3950.00
(Single User License)
Global Oligonucleotide Market Research Report 2024
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published Date: 2024-01-04
Pages: 110
USD 2900.00
(Single User License)
Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oligonucleotide was estimated to be worth US$ 1666 million in 2025 and is projected to reach US$ 3237 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 144
USD 3950.00 (Single User License)Global Oligonucleotide Market Research Report 2026
The global Oligonucleotide market was valued at US$ 1666 million in 2025 and is anticipated to reach US$ 3237 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 137
USD 2900.00 (Single User License)Global Oligonucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oligonucleotide market size was US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 92
USD 4250.00 (Single User License)Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oligonucleotide was estimated to be worth US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 114
USD 3950.00 (Single User License)Global Oligonucleotide Market Research Report 2025
The global market for Oligonucleotide was valued at US$ 1527 million in the year 2024 and is projected to reach a revised size of US$ 2967 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published: 2025-02-24
Pages: 101
USD 2900.00 (Single User License)Oligonucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published: 2024-01-16
Pages: 144
USD 3950.00 (Single User License)Global Oligonucleotide Market Research Report 2024
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published: 2024-01-04
Pages: 110
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now